These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23613900)
1. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells. Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900 [TBL] [Abstract][Full Text] [Related]
2. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines. Qian H; Tao Y; Jiang L; Wang Y; Lan T; Wu M; Pang J; Appiah-Kubi K; Chen Y; Wu Y Cell Biol Int; 2018 Apr; 42(4):435-442. PubMed ID: 29150923 [TBL] [Abstract][Full Text] [Related]
3. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells. Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906 [TBL] [Abstract][Full Text] [Related]
4. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Wu Y; Chen Y; Qu R; Lan T; Sang J Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247 [TBL] [Abstract][Full Text] [Related]
5. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells. Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826 [TBL] [Abstract][Full Text] [Related]
6. Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells. Li D; Hua Y; Jiang L; Huang Y; Yue J; Wu Y; Chen Y Med Sci Monit; 2018 Apr; 24():1997-2002. PubMed ID: 29617357 [TBL] [Abstract][Full Text] [Related]
7. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells. Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186 [TBL] [Abstract][Full Text] [Related]
8. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells. Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605 [TBL] [Abstract][Full Text] [Related]
9. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells. Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031 [TBL] [Abstract][Full Text] [Related]
10. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells. Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012 [TBL] [Abstract][Full Text] [Related]
11. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation. Lan T; Pang J; Wang Z; Wang Y; Qian H; Chen Y; Wu Y Biochem Biophys Res Commun; 2019 Oct; 518(1):14-18. PubMed ID: 31395339 [TBL] [Abstract][Full Text] [Related]
12. Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells. Zhu M; Yao X; Wu M; Qian H; Wu Y; Chen Y Mol Med Rep; 2016 Feb; 13(2):1909-13. PubMed ID: 26676300 [TBL] [Abstract][Full Text] [Related]
13. PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells. Wu Y; Yao X; Zhu M; Qian H; Jiang L; Lan T; Wu M; Pang J; Chen Y Oncotarget; 2016 Jun; 7(23):34190-200. PubMed ID: 27147579 [TBL] [Abstract][Full Text] [Related]
14. Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells. Cao ZH; Tao Y; Sang JR; Gu YJ; Bian XJ; Chen YC Mol Med Rep; 2013 Apr; 7(4):1229-34. PubMed ID: 23404188 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase. Yao X; Wu Y; Zhu M; Qian H; Chen Y Oncol Lett; 2015 Jul; 10(1):479-484. PubMed ID: 26171055 [TBL] [Abstract][Full Text] [Related]
16. Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells. Wu M; Wu Y; Qian H; Tao Y; Pang J; Wang Y; Chen Y Mol Med Rep; 2017 Oct; 16(4):5729-5737. PubMed ID: 28849123 [TBL] [Abstract][Full Text] [Related]
17. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines. Jiang LU; Wu M; Wu Y; Lan T; Wang Y; Qian H; Chen Y Oncol Lett; 2015 Jun; 9(6):2781-2786. PubMed ID: 26137146 [TBL] [Abstract][Full Text] [Related]
18. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells. Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059 [TBL] [Abstract][Full Text] [Related]
19. Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239. Tao Y; Gu YJ; Cao ZH; Bian XJ; Lan T; Sang JR; Jiang L; Wang Y; Qian H; Chen YC Oncol Lett; 2012 Nov; 4(5):1104-1108. PubMed ID: 23162660 [TBL] [Abstract][Full Text] [Related]
20. Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells. Jiang L; Chen Y; Sang J; Li Y; Lan T; Wang Y; Tao Y; Qian H Biomed Rep; 2013 May; 1(3):399-404. PubMed ID: 24648957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]